Thrombolytic efficacy of recombinant human microplasmin in a canine model of copper coil-induced coronary artery thrombosis

Journal of Thrombosis and Thrombolysis

Volumn 30, Issue 1, 2010, Pages 46-54

  Dommke, Christophe ^a   Turschner, Oliver ^a,b   Stassen, Jean Marie ^c   Van De Werf, Frans ^a   Lijnen, H Roger ^d   Verhamme, Peter ^a,d  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b KLINIKUM COBURG   (Germany)

^c ThromboGenics NV   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Acute myocardial infarction; Microplasmin; Plasmin; Thrombolysis

Indexed keywords

ABCIXIMAB; CHROMOGENIC SUBSTRATE; COPPER; FIBRIN; PLASMIN; PYROGLUTAMYLGLYCYLARGININE 4 NITROANILIDE; RECOMBINANT MICROPLASMIN; RECOMBINANT PROTEIN; S 2403; UNCLASSIFIED DRUG; OCRIPLASMIN; OLIGOPEPTIDE; PEPTIDE FRAGMENT;

AMIDOLYTIC; ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BOLUS INJECTION; CATALYSIS; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY THROMBOSIS; DOG; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; FIBRIN CLOT; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; ANGIOGRAPHY; ANIMAL; CORONARY THROMBOSIS; DIAGNOSTIC USE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PROCEDURES; TREATMENT OUTCOME;

ANGIOGRAPHY; ANIMALS; CORONARY THROMBOSIS; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYSIN; FIBRINOLYSIS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 77953869098     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0400-9     Document Type: Article

References (20)

1. N Nagai E Demarsin HB Van, et al. 2003 Recombinant human microplasmin: production and potential therapeutic properties J Thromb Haemost 1 307 313 10.1046/j.1538-7836.2003.00078.x 1:CAS:528:DC%2BD2cXktFemsrs%3D 12871505
2. GL Reed III GR Matsueda E Haber 1990 Synergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin Proc Natl Acad Sci USA 87 1114 1118 10.1073/pnas.87.3.1114 1:CAS:528:DyaK3cXhtlaitrs%3D 1689060
3. SR Bergmann KA Fox MM Ter-Pogossian BE Sobel D Collen 1983 Clot-selective coronary thrombolysis with tissue-type plasminogen activator Science 220 1181 1183 10.1126/science.6602378 1:STN:280:DyaL3s3itlGmuw%3D%3D 6602378
4. LR Bush RJ Shebuski 1990 In vivo models of arterial thrombosis and thrombolysis FASEB J 4 3087 3098 1:CAS:528:DyaK3MXitFKgug%3D%3D 2210155
5. Van De Werf SR Bergmann KA Fox, et al. 1984 Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology Circulation 69 605 610 1:CAS:528:DyaL2cXhsFSrsbw%3D 6362907
6. D Collen D Stump WF Van De IK Jang M Nobuhara HR Lijnen 1985 Coronary thrombolysis in dogs with intravenously administered human pro-urokinase Circulation 72 384 388 1:STN:280:DyaL2M3ivVOisA%3D%3D 3924437
7. Van De Werf IK Jang D Collen 1987 Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis J Cardiovasc Pharmacol 9 91 93 1:CAS:528:DyaL2sXpsFynuw%3D%3D 2434801
8. SV Pislaru L Barrios T Stassen L Jun C Pislaru WF Van De 1997 Infarct size, myocardial hemorrhage, and recovery of function after mechanical versus pharmacological reperfusion: effects of lytic state and occlusion time Circulation 96 659 666 1:STN:280:DyaK2szos1eqsw%3D%3D 9244240
9. HR Lijnen HB Van D Collen 1987 Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin Eur J Biochem 169 359 364 10.1111/j.1432-1033.1987.tb13620.x 1:CAS:528:DyaL1cXis1Ci 2961562 (Pubitemid 18005406)
10. B Wiman HR Lijnen D Collen 1979 On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen Biochim Biophys Acta 579 142 154 1:CAS:528:DyaE1MXltVCnur8%3D 157166
11. B Wiman 1980 Affinity-chromatographic purification of human alpha 2-antiplasmin Biochem J 191 229 232 1:CAS:528:DyaL3MXktlWltQ%3D%3D 6907016
12. SV Pislaru C Pislaru X Zhu, et al. 1998 Comparison of a synthetic antithrombin III-binding pentasaccharide and standard heparin as an adjunct to coronary thrombolysis Thromb Haemost 79 1130 1135 1:CAS:528:DyaK1cXjvVWmu7c%3D 9657437
13. Y Sakata Y Eguchi J Mimuro M Matsuda Y Sumi 1989 Clot lysis induced by a monoclonal antibody against alpha 2-plasmin inhibitor Blood 74 2692 2697 1:CAS:528:DyaK3cXltlCitg%3D%3D 2510836
14. T Svilaas PJ Vlaar I van dH, et al. 2008 Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 557 567 10.1056/NEJMoa0706416 1:CAS:528:DC%2BD1cXhsF2rsL8%3D 18256391 (Pubitemid 351214283)
15. VJ Marder K Landskroner V Novokhatny, et al. 2001 Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit Thromb Haemost 86 739 745 1:CAS:528:DC%2BD3MXnsVejtr8%3D 11583303
16. VV Novokhatny GJ Jesmok KA Landskroner VJ Marder TP Zimmerman 2004 Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis? Trends Pharmacol Sci 25 72 75 10.1016/j.tips.2003.12. 009 1:CAS:528:DC%2BD2cXhtVOrt74%3D 15102492 (Pubitemid 38183392)
17. VJ Marder 2008 Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator Thromb Res 122 Suppl 3 S9 S15 10.1016/j.thromres.2008.06.019 1:CAS:528:DC%2BD1cXhtVyis7nL 18722003
18. SR Deitcher WD Funk J Buchanan S Liu MD Levy CF Toombs 2006 Alfimeprase: a novel recombinant direct-acting fibrinolytic Expert Opin Biol Ther 6 1361 1369 10.1517/14712598.6.12.1361 1:CAS:528:DC%2BD28Xht1eks7vJ 17223743 (Pubitemid 44875689)
19. Verhamme P, Jerome M, Goossens G, Devis J, Maleux G, Stas M (2009) A pilot trial of microplasmin in patients with long-term venous access catheter thrombosis. J Thromb Thrombolysis. 2009 Feb 19 [Epub ahead of print]
20. RD Shlansky-Goldberg AH Matsumoto GA Baumbach, et al. 2008 A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion J Thromb Haemost 6 944 950 10.1111/j.1538-7836.2008.02969.x 1:CAS:528:DC%2BD1cXotFaqtLY%3D 18384651 (Pubitemid 351689915)